Mental Health Treatments - FOI Response Register

I am trying to understand the medications and provision of mental health services that is taking place in the UK. Specifically, can you inform me of the following for the financial year 2023/2024:

1. Patients treated with 1st or 2nd generation antipsychotic treatments:
   1. Number of patients treated with 1st and 2nd generation medications

2. If possible, indicate the number of patients, above, by medication

1st Generation medications

2nd Generation Medications

Where we have given <5 answers, this is because NHS Shetland considers that providing more specific information carries a high risk of identifying individuals and/or disclosing information about individuals. As such, and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.

2. Tetrabenazine usage. I am trying to determine the disease areas for the usage of Tetrabenazine.

Therefore, where possible to split the usage between the following disease areas:

In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested. NHS Shetland do not hold information related to indication related prescribing.

3. I am also trying to define the treatment sites for mental health provision within both the hospital and community settings, e.g.

Community Mental Health Team, Lerwick Health Centre, Lerwick, ZE1 0RB

If services are not provided by the Health Board, please indicate the relevant Health Board which provides these services.